General Pain

Latest

Primary Care Clinics May Be Hesitant to Accept New Patients Taking Opioids for Chronic Pain

By

Tyler Rice

Patients who take prescription opioids for chronic pain may have difficulty receiving treatment as new patients at primary care clinics.

Online Symptom Self-Management With Physician Telehealth Aids Pain, Mood

Online symptom self-management plus clinician telecare can be effective for individuals with pain, depression, and anxiety.

FDA Recalls Herbal Medications Being Marketed for Various Diseases

By

Steve Duffy

In addition to being manufactured outside of the controls required by current Good Manufacturing Practices, these products are also being marketed for diseases without FDA approval.

How Often Does the FDA Disagree With Its Advisory Committees’ Recommendations?

By

Cassandra Pardini, PharmD

According to the findings of a recent review, the Food and Drug Administration rarely disagrees with recommendations made by its advisory committees.

Inpatient Opioid Administration Patterns Linked to Post-Discharge Use in Opioid-Naive Patients

By

Clinical Pain Advisor Contributing Writer

Rates of opioid administration were found to be high in opioid-naive inpatients.

Public Disclosure of New Drug and Biologics Application Filing With the FDA

By

Clinical Pain Advisor Contributing Writer

Investigators sought to determine how frequently information treated as confidential with regard to New Drug Applications or Biologics License Applications is available to the public.

Reviewing Off-Label Uses of Gabapentinoids

By

Tori Rodriguez, MA, LPC

As part of current efforts to reduce unnecessary opioid consumption, clinicians have increasingly prescribed gabapentinoids for a range of pain disorders.

FDA Draft Guidance Seeks to Improve Drug Abuse, Dependence Information in Labeling

By

Diana Ernst, RPh

The FDA is looking to make the information in the Drug Abuse and Dependence section of product labeling more consistent and clear through a new draft guidance.

Case Study: Progressive Abdominal Pain

By

Brady Pregerson, MD

A man presents to the emergency department with progressive, right-sided abdominal and flank pain for 3 days.

Review Investigates Adverse Effects of Cannabidiol

By

Diana Ernst, RPh

The use of cannabidiol (CBD), the non-intoxicating component of cannabis, has been associated with numerous adverse effects based on available evidence from animal and human studies.